We are live on
!
Find out more
FRA
Front Row Advisors Portfolio holdings
AUM
$296M
1-Year Est. Return
34.73%
This Fund
S&P 500
This Quarter
Est. Return
+5.24%
1 Year Est. Return
+34.73%
3 Year Est. Return
+122.22%
5 Year Est. Return
+164.22%
10 Year Est. Return
–
AUM
$206M
AUM Growth
+$11.3M
(+5.8%)
Cap. Flow
+$3.15M
Cap. Flow
% of AUM
1.53%
Top 10 Holdings %
Top 10 Hldgs %
29.46%
Holding
991
New
61
Increased
179
Reduced
212
Closed
41
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$782K |
| 2 |
ASML
ASML
|
+$199K |
| 3 |
Apple
AAPL
|
+$193K |
| 4 |
Keysight
KEYS
|
+$158K |
| 5 |
Micron Technology
MU
|
+$155K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BEAT
BioTelemetry, Inc.
BEAT
|
+$2.06M |
| 2 |
iShares Gold Trust
IAU
|
+$145K |
| 3 |
IBDM
iShares iBonds Dec 2021 Term Corporate ETF
IBDM
|
+$99.5K |
| 4 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$55.2K |
| 5 |
Lowe's Companies
LOW
|
+$51.5K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.51% |
| 2 | Healthcare | 14.12% |
| 3 | Consumer Staples | 7.95% |
| 4 | Financials | 7.59% |
| 5 | Consumer Discretionary | 5.07% |
Similar funds
SM
RHP
MSWM
RLIM
JCM
CA
KNFPWM
NRC
Front Row Advisors's Q1 2021 Portfolio in Review
As of Q1 2021, Front Row Advisors held 991 positions worth $206M, up 5.8% from $195M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Front Row Advisors's Q1 2021 filing shows 61 new, 179 increased, 212 reduced and 41 closed positions. Its largest new stake was State Street SPDR Portfolio Mortgage Backed Bond ETF: 4,000 shares worth $104K. The largest sale was BioTelemetry, Inc., an estimated $2.06M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Healthcare and Consumer Staples.
- Front Row Advisors's largest Q1 2021 buy was State Street SPDR Portfolio Mortgage Backed Bond ETF: 4,000 shares worth $104K.
- Front Row Advisors added most to Walmart Inc in Q1 2021, an estimated $782K increase.
- Front Row Advisors's biggest Q1 2021 reduction was iShares iBonds Dec 2021 Term Corporate ETF, cutting an estimated $99.5K.
- Front Row Advisors fully exited BioTelemetry, Inc. in Q1 2021, selling an estimated $2.06M.
- Front Row Advisors's ten largest holdings make up 29% of its $206M portfolio in Q1 2021.
- Front Row Advisors opened 61 new positions and closed 41 in Q1 2021.
- Front Row Advisors's portfolio value rose 5.8% quarter-over-quarter to $206M.
Based on Front Row Advisors's 13F filing for Q1 2021, filed 28 Apr 2021.